Авторы

  • Абдуллаева Н.Ш., Ражабова З.А., Холиков Ф.Ж., Каримов Х.Я., Бобоев К.Т.

Ключевые слова:

ETP-ОЛЛ, острый лимфобластный лейкоз, миелограмма, общий анализ крови, иммунофенотипирование, бласты.

Библиографические ссылки

Anand P, Guillaumet-Adkins A, Dimitrova V, Yun H, Drier Y, Sotudeh N, et al. Single Cell RNA-Seq Reveals Developmental Plasticity With Coexisting Oncogenic and Immune Evasion Programs in ETP-ALL. Blood (2021) 137(18): 2463–80. doi: 10. 1182/blood.2019004547.

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 Revision to the World Health Organization Classification of Myeloid Neoplasms and Acute Leukemia. Blood (2016) 127:2391–405. doi: 10.1182/blood-2016-03-64354

Bayon-Calderon F, Toribio ML, Gonzalez-Garcia S. Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci (2020) 21:1–35. doi: 10.3390/ijms21207685.

Bene M., Castoldi G., Knapp W., et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 19 95; 9(10): 1783-1786.

Bond J, Krzywon A, Lhermitte L, Roumier C, Roggy A, Belhocine M, et al. A Transcriptomic Continuum of Differentiation Arrest Identifies Myeloid Interface Acute Leukemias With Poor Prognosis. Leukemia (2021) 35:724–36. doi: 10.1038/s41375-020-0965-z.

Cancela, C. S. P., Murao, M., Assumpção, J. G., Souza, M. E. de L., de Macedo, A. V., Viana, M. B., & De Oliveira, B. M. (2017). Immunophenotyping of the cerebrospinal fluid as a prognostic factor at diagnosis of acute lymphoblastic leukemia in children and adolescents. Pediatric Hematology and Oncology, 34 (2), 53–65. doi:10.1080/08880018.2017.1313920.

Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D, et al. Early T-Cell Precursor Leukaemia: A Subtype of Very High-Risk Acute Lymphoblastic Leukaemia. Lancet Oncol (2009) 10:147–56. doi: 10.1016/S1470-2045(08)70 314-0.

Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, et al. AIEOP-BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia. Cytometry B Clin Cytom (2018) 94:82–93. doi: 10.10 02/cyto.b.21518.

Guru Murthy GS, Pondaiah SK, Abedin S, Atallah E. Incidence and Survival of T-Cell Acute Lymphoblastic Leukemia in the United States. Leuk Lymphoma (2019) 60:1171–8. doi: 10.1080/104281 94.2018.1522442.

Jain N, Lamb AV, O'Brien S, Ravandi F, Konopleva M, Jabbour E, et al. Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma (ETP-ALL/LBL) in Adolescents and Adults: A High-Risk Subtype. Blood (2016) 127:1863–9. doi: 10.1182/ blood-2015-08-661702.

Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, et al. Early T Precursor Acute Lymphoblastic Leukaemia/Lymphoma Shows Differential Immunophenotypic Characteristics Including Frequent CD33 Expression and. Vitro Response to Targeted CD33 Ther Br J Haematol (2019) 186: 538–48. doi: 10.1111/bjh.15960.

Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, et al. Outcome of T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Focus on Near-ETP Phenotype and Differential Impact of Nelarabine. Am J Hematol (2021) 96:589–98. doi: 10.1002/ajh.26144.

Noronha EP, Marques LVC, Andrade FG, Sardou-Cezar I, Dos Santos-Bueno FV, Zampier CDP, et al. T-Lymphoid/Myeloid Mixed Phenotype Acute Leukemia and Early T-Cell Precursor Lymphoblastic Leukemia Similarities With NOTCH1 Mutation as a Good Prognostic Factor. Cancer Manag Res (2019) 11:3933–43. doi: 10.2147/CMAR.S196574.

Raetz EA, Teachey DT. T-Cell Acute Lymphoblastic Leukemia. Hematol Am Soc Hematol Educ Program (2016) 2016:580–8. doi: 10.1182/asheducation-2016.1.580.

Rafei H, Kantarjian HM, Jabbour EJ. Recent Advances in the Treatment of Acute Lymphoblastic Leukemia. Leuk Lymphoma (2019) 60:2606–21. doi: 10.1080/10428194.2019.1605071.

Sin C., Man P. M. Early T-cell precursor acute lymphoblastic leukemia: Diagnosis, updates in molecular pathogenesis, management, and novel the rapies //Frontiers in Oncology.

Tavakoli Shirazi P, Eadie LN, Heatley SL, Hughes TP, Yeung DT, White DL. The Effect of Co-Occurring Lesions on Leukaemogenesis and Drug Response in T-ALL and ETP-ALL. Br J Cancer (2020) 122:455–64. doi: 10.1038/s41416-019-0647-7.

You MJ, Medeiros LJ, Hsi ED. T-Lymphoblastic Leukemia/Lymphoma. Am J Clin Pathol (20 15) 144:411–22. doi: 10.1309/AJCPMF03LVSBLHPJ.

Zuurbier L, Gutierrez A, Mullighan CG, Cante-Barrett K, Gevaert AO, de Rooi J, et al. Immature MEF2C-Dysregulated T-Cell Leukemia Patients Have an Early T-Cell Precursor Acute Lymphoblastic Leukemia Gene Signature and Typically Have Non-Rearranged T-Cell Receptors. Haematologica (2014) 99:94–102. doi: 10.3324/haematol.2013.090233.